Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New gene test may help identify prostate cancer:

This article was originally published in Clinica

Executive Summary

A new gene test could help doctors to detect prostate cancer more reliably from tissue samples, according to US researchers at the University of Michigan Medical School. The gene, called AMACR, was reported to be over-expressed in prostate cancer samples and may be a useful diagnostic biomarker in difficult-to-diagnose samples. Study leader, Mark Rubin, reported the gene test to be 97% sensitive and 100% specific for the disease. The findings are published in the Journal of the American Medical Association (April 3).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065964

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel